Boston Scientific: Symetis Acquisition

3/31/17

Quick Take

Medical technology company Boston Scientific (BSX) has announced an agreement to acquire aortic valve medical device maker Symetis for $435 million in an all cash transaction.

The global structural heart market is expected to grow rapidly, and Boston Scientific’s acquisition of Symetis promises to take full advantage of that growth opportunity.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.